On Friday, February 7, 2014, Merck & Co announced that it is willing to pay $100 million to settle all NuvaRing intrauterine contraceptive device lawsuits.
The NuvaRing contraceptive is a flexible ring that releases the hormones estrogen and progestin in order to prevent pregnancy. NuvaRing has been associated with an increased risk of forming blood clots, which can in turn cause heart attacks, strokes, even death. An FDA report released in 2011 announced that NuvaRing posed a higher risk for blood ...
continue reading...
Johnson & Johnson (J&J) and its subsidiaries have agreed to pay over $2.2 billion in criminal and civil fines arising out of false marketing claims. The company allegedly promoted off-label uses for various drugs, and provided kickbacks to doctors and pharmacists for prescribing those drugs. The drugs at issue in this suit include 